Thursday, April 18th, 2013
Men and women diagnosed with Fibromyalgia, ages 21-70 needed. The University of Washington’s Fibromyalgia Research Program is conducting a study supported by a grant from the NIH. This is a randomized (like flipping a coin) study that involves the combination of a drug treatment, behavioral health treatments, and placebo controls. We plan to evaluate different combinations of these treatments for people with Fibromyalgia, to see which ones work best and for whom. Participation in the study will require 13 visits over a 15 week period with a follow up 6 months after treatment.
Qualified participants may receive a comprehensive medical evaluation and a combination of pharmacological and behavioral health treatment. Individuals may be included in this study if they are fluent in English, have been diagnosed with Fibromyalgia, and currently have a primary healthcare provider. There are some additional requirements that may exclude you from the study. Participants may be compensated up to $300 upon completion of the study. Please contact us today to find out more about the study.
University of Washington
Fibromyalgia Research Program
TEL: (206) 221-1737
(we cannot guarantee the confidentiality of any information sent by e-mail)
Study site location for participation:
University District Building
1107 Northeast 45th Street
Seattle, WA 98105